IkB kinase β (IKKβ) inhibits p63 Isoform γ (TAp63γ) transcriptional activity

Journal of Biological Chemistry

Volumn 288, Issue 25, 2013, Pages 18184-18193

  Liao, Jun Ming ^a   Zhang, Yu ^a   Liao, Wenjuan ^a   Zeng, Sheyla X ^a   Su, Xiaohua ^b   Flores, FloresElsa R ^b   Lu, Hua ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNCTIONAL REGULATION; ISOFORMS; TRANSCRIPTIONAL ACTIVITY;

CELL PROLIFERATION;

ENZYMES;

E1A ASSOCIATED P300 PROTEIN; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; MICRORNA 34A; PROTEIN P21; PROTEIN P63; PROTEIN P63 ISOFORM GAMMA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 2 AMINO 6 (2 (CYCLOPROPYLMETHOXY) 6 HYDROXYPHENYL) 4 PIPERIDIN 4 YL NICOTINONITRILE; 2-AMINO-6-(2-(CYCLOPROPYLMETHOXY)-6-HYDROXYPHENYL)-4-PIPERIDIN-4-YL NICOTINONITRILE; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; EP300 PROTEIN, HUMAN; I KAPPA B KINASE; ISOPROTEIN; MICRORNA; MIRN34 MICRORNA, HUMAN; NICOTINIC ACID DERIVATIVE; NITRILE; SERINE; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ACETYLATION; ARTICLE; CONTROLLED STUDY; MASS SPECTROMETRY; PHOSPHORYLATION; PREDICTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; BINDING SITE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; HUMAN; IΚB KINASE-Β; METABOLISM; MUTATION; P300; P63; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION; TRANSCRIPTION INITIATION; TUMOR CELL LINE; TUMOR NECROSIS FACTOR (TNF); WESTERN BLOTTING;

IΚB KINASE-Β; P300; P63; SENESCENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION; TUMOR NECROSIS FACTOR (TNF);

BINDING SITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; E1A-ASSOCIATED P300 PROTEIN; GENE EXPRESSION; HUMANS; I-KAPPA B KINASE; MICRORNAS; MUTATION; NICOTINIC ACIDS; NITRILES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

EID: 84880072895     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.466540     Document Type: Article

References (43)

1. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., and McKeon, F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2, 305-316 (Pubitemid 128379271)
2. Dötsch, V., Bernassola, F., Coutandin, D., Candi, E., and Melino, G. (2010) p63 and p73, the ancestors of p53. Cold Spring Harbor Persp. Biol. 2, a004887
3. Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obinata, M., and Ikawa, S. (1998) Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med. 4, 839-843 (Pubitemid 28331028)
4. Serber, Z., Lai, H. C., Yang, A., Ou, H. D., Sigal, M. S., Kelly, A. E., Darimont, B. D., Duijf, P. H., Van Bokhoven, H., McKeon, F., and Dötsch, V. (2002) A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Mol. Cell. Biol. 22, 8601-8611 (Pubitemid 35397175)
5. Koster, M. I., Kim, S., Mills, A. A., DeMayo, F. J., and Roop, D. R. (2004) p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 18, 126-131 (Pubitemid 38141780)
6. MacPartlin, M., Zeng, S., Lee, H., Stauffer, D., Jin, Y., Thayer, M., and Lu, H. (2005) p300 regulates p63 transcriptional activity. J. Biol. Chem. 280, 30604-30610 (Pubitemid 41216246)
7. Koster, M. I., Kim, S., Huang, J., Williams, T., and Roop, D. R. (2006) TAp63α induces AP-2γ as an early event in epidermal morphogenesis. Dev. Biol. 289, 253-261 (Pubitemid 41804103)
8. Michael, D., and Oren, M. (2002) The p53 and Mdm2 families in cancer. Curr. Opin. Genet. Dev. 12, 53-59 (Pubitemid 34094990)
9. Celli, J., Duijf, P., Hamel, B. C., Bamshad, M., Kramer, B., Smits, A. P., Newbury-Ecob, R., Hennekam, R. C., Van Buggenhout, G., van Haeringen, A., Woods, C. G., van Essen, A. J., de Waal, R., Vriend, G., Haber, D. A., Yang, A., McKeon, F., Brunner, H. G., and van Bokhoven, H. (1999) Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 99, 143-153 (Pubitemid 29491781)
10. Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R., and Karin, M. (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKK+ subunit of IkB kinase. Science 284, 316-320
11. Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., Terada, N., and Akira, S. (1999) Limb and skin abnormalities in mice lacking IKK+. Science 284, 313-316
12. Ianakiev, P., Kilpatrick, M. W., Toudjarska, I., Basel, D., Beighton, P., and Tsipouras, P. (2000) Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am. J. Hum. Genet. 67, 59-66 (Pubitemid 30481544)
13. McGrath, J. A., Duijf, P. H., Doetsch, V., Irvine, A. D., de Waal, R., Vanmolkot, K. R., Wessagowit, V., Kelly, A., Atherton, D. J., Griffiths, W. A., Orlow, S. J., van Haeringen, A., Ausems, M. G., Yang, A., McKeon, F., Bamshad, M. A., Brunner, H. G., Hamel, B. C., and van Bokhoven, H. (2001) Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum. Mol. Genet. 10, 221-229 (Pubitemid 32123980)
14. van Bokhoven, H., Hamel, B. C., Bamshad, M., Sangiorgi, E., Gurrieri, F., Duijf, P. H., Vanmolkot, K. R., van Beusekom, E., van Beersum, S. E., Celli, J., Merkx, G. F., Tenconi, R., Fryns, J. P., Verloes, A., Newbury-Ecob, R. A., Raas-Rotschild, A., Majewski, F., Beemer, F. A., Janecke, A., Chitayat, D., Crisponi, G., Kayserili, H., Yates, J. R., Neri, G., and Brunner, H. G. (2001) p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am. J. Hum. Genet. 69, 481-492 (Pubitemid 32777688)
15. Mills, A. A., Zheng, B., Wang, X. J., Vogel, H., Roop, D. R., and Bradley, A. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398, 708-713 (Pubitemid 29197649)
16. Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C., and McKeon, F. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398, 714-718 (Pubitemid 29197650)
17. Israël, A., Le Bail, O., Hatat, D., Piette, J., Kieran, M., Logeat, F., Wallach, D., Fellous, M., and Kourilsky, P. (1989) TNF stimulates expression of mouse MHC class I genes by inducing an NFkB-like enhancer binding activity which displaces constitutive factors. EMBO J. 8, 3793-3800 (Pubitemid 20016060)
18. DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., and Karin, M. (1997) A cytokine-responsive IkB kinase that activates the transcription factor NF-kB. Nature 388, 548-554 (Pubitemid 27339997)
19. Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J., Young, D. B., Barbosa, M., Mann, M., Manning, A., and Rao, A. (1997) IKK-1 and IKK-2: Cytokine-activated IkB kinases essential for NF-kB activation. Science 278, 860-866 (Pubitemid 27467923)
20. MacPartlin, M., Zeng, S. X., and Lu, H. (2008) Phosphorylation and stabilization of TAp63α by IkB kinase-β. J. Biol. Chem. 283, 15754-15761
21. He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., Jackson, A. L., Linsley, P. S., Chen, C., Lowe, S. W., Cleary, M. A., and Hannon, G. J. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134 (Pubitemid 47014436)
22. Jin, Y., Zeng, S. X., Sun, X. X., Lee, H., Blattner, C., Xiao, Z., and Lu, H. (2008) MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2. Mol. Cell. Biol. 28, 1218-1229 (Pubitemid 351214125)
23. Zhang, Y., Liao, J. M., Zeng, S. X., and Lu, H. (2011) p53 downregulates Down syndrome-associated DYRK1A through miR-1246. EMBO Reports 12, 811-817
24. Zeng, S. X., Dai, M. S., Keller, D. M., and Lu, H. (2002) SSRP1 functions as a co-activator of the transcriptional activator p63. EMBO J. 21, 5487-5497 (Pubitemid 35231028)
25. Tang, F., Hajkova, P., Barton, S. C., Lao, K., and Surani, M. A. (2006) MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res. 34, e9
26. Dai, M. S., Sun, X. X., and Lu, H. (2008) Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol. Cell. Biol. 28, 4365-4376 (Pubitemid 351904958)
27. Jin, Y., Dai, M. S., Lu, S. Z., Xu, Y., Luo, Z., Zhao, Y., and Lu, H. (2006) 14-3-3γ binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J. 25, 1207-1218
28. Liao, J. M., and Lu, H. (2011) Autoregulatory suppression of c-Myc by miR-185-3p. J. Biol. Chem. 286, 33901-33909
29. Zhang, Q., Xiao, H., Chai, S. C., Hoang, Q. Q., and Lu, H. (2011) Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation. J. Biol. Chem. 286, 38264-38274
30. Antonini, D., Russo, M. T., De Rosa, L., Gorrese, M., Del Vecchio, L., and Missero, C. (2010) Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells. J. Investig. Dermatol. 130, 1249-1257
31. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (Pubitemid 23346378)
32. Lin, Y. L., Sengupta, S., Gurdziel, K., Bell, G. W., Jacks, T., and Flores, E. R. (2009) p63 and p73 transcriptionally regulate genes involved in DNA re-pair. PLoS Genetics 5, e1000680
33. Su, X., Gi, Y. J., Chakravarti, D., Chan, I. L., Zhang, A., Xia, X., Tsai, K. Y., and Flores, E. R. (2012) TAp63 is a master transcriptional regulator of lipid and glucose metabolism. Cell Metab. 16, 511-525
34. Murata, T., Shimada, M., Sakakibara, S., Yoshino, T., Kadono, H., Masuda, T., Shimazaki, M., Shintani, T., Fuchikami, K., Sakai, K., Inbe, H., Takeshita, K., Niki, T., Umeda, M., Bacon, K. B., Ziegelbauer, K. B., and Lowinger, T. B. (2003) Discovery of novel and selective IKK-e serinethreonine protein kinase inhibitors. Part 1. Bioorganic Medicinal Chemistry Letters 13, 913-918 (Pubitemid 36255566)
35. Han, Z., Wei, W., Dunaway, S., Darnowski, J. W., Calabresi, P., Sedivy, J., Hendrickson, E. A., Balan, K. V., Pantazis, P., and Wyche, J. H. (2002) Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J. Biol. Chem. 277, 17154-17160 (Pubitemid 34967748)
36. Romanov, V. S., Abramova, M. V., Svetlikova, S. B., Bykova, T. V., Zubova, S. G., Aksenov, N. D., Fornace, A. J., Jr., Pospelova, T. V., and Pospelov, V. A. (2010) p21(Waf1) is required for cellular senescence but not for cell cycle arrest induced by the HDAC inhibitor sodium butyrate. Cell Cycle 9, 3945-3955
37. Hwang, I., Thorgeirsson, T., Lee, J., Kustu, S., and Shin, Y. K. (1999) Physical evidence for a phosphorylation-dependent conformational change in the enhancer-binding protein NtrC. Proc. Natl. Acad. Sci. U.S.A. 96, 4880-4885 (Pubitemid 29218500)
38. Tang, G., Yang, J., Minemoto, Y., and Lin, A. (2001) Blocking caspase-3-mediated proteolysis of IKK+ suppresses TNF-α-induced apoptosis. Mol. Cell 8, 1005-1016 (Pubitemid 34031803)
39. Maeda, S., Chang, L., Li, Z. W., Luo, J. L., Leffert, H., and Karin, M. (2003) IKK+ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19, 725-737 (Pubitemid 37490797)
40. Senftleben, U., Li, Z. W., Baud, V., and Karin, M. (2001) IKK+ is essential for protecting T cells from TNFα-induced apoptosis. Immunity 14, 217-230 (Pubitemid 32289287)
41. Ak, P., and Levine, A. J. (2010) p53 and NF-kB: Different strategies for responding to stress lead to a functional antagonism. Faseb. J. 24, 3643-3652
42. Maltzman, W., and Czyzyk, L. (1984) UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4, 1689-1694 (Pubitemid 14008276)
43. O'Dea, E. L., Kearns, J. D., and Hoffmann, A. (2008) UV as an amplifier rather than inducer of NF-kB activity. Mol. Cell 30, 632-641 (Pubitemid 351755056)